Psygen Receives Dealer’s Licence from Health Canada Post published:January 17, 2022 Post category:Press Release
Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio Post published:October 6, 2021 Post category:Press Release
Psygen Announces Successful Closing of Oversubscribed Convertible Debenture Financing, Sets Value at $30mm Post published:August 5, 2021 Post category:Press Release
Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord Post published:March 24, 2021 Post category:Press Release
Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion of Initial DMT Research Drug Batch and Exercise of Warrants Post published:December 9, 2020 Post category:Press Release